Spain strangles brands as PPP falls to 14-year low
This article was originally published in Scrip
Executive Summary
More angst for the producers of innovative and branded drugs as the latest figures from Spain indicate that the total drug spend down 4.45% in the first quarter of 2012 compared to the same period in 2011, despite the fact that the number of paid prescriptions issued rose by 2.19%.